• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有效促进公众参与医疗保健改善和政策决策的关键要素有哪些?一项随机试验的过程评估。

What are the key ingredients for effective public involvement in health care improvement and policy decisions? A randomized trial process evaluation.

机构信息

Université de Sherbrooke.

出版信息

Milbank Q. 2014 Jun;92(2):319-50. doi: 10.1111/1468-0009.12060.

DOI:10.1111/1468-0009.12060
PMID:24890250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4089374/
Abstract

CONTEXT

In the past 50 years, individual patient involvement at the clinical consultation level has received considerable attention. More recently, patients and the public have increasingly been involved in collective decisions concerning the improvement of health care and policymaking. However, rigorous evaluation guiding the development and implementation of effective public involvement interventions is lacking. This article describes those key ingredients likely to affect public members' ability to deliberate productively with professionals and influence collective health care choices.

METHOD

We conducted a trial process evaluation of public involvement in setting priorities for health care improvement. In all, 172 participants (including 83 patients and public members and 89 professionals) from 6 Health and Social Services Centers in Canada participated in the trial. We video-recorded 14 one-day meetings, and 2 nonparticipant observers took structured notes. Using qualitative analysis, we show how public members influenced health care improvement priorities.

FINDINGS

Legitimacy, credibility, and power explain the variations in the public members' influence. Their credibility was supported by their personal experience as patients and caregivers, the provision of a structured preparation meeting, and access to population-based data from their community. Legitimacy was fostered by the recruitment of a balanced group of participants and by the public members' opportunities to draw from one another's experience. The combination of small-group deliberations, wider public consultation, and a moderation style focused on effective group process helped level out the power differences between professionals and the public. The engagement of key stakeholders in the intervention design and implementation helped build policy support for public involvement.

CONCLUSIONS

A number of interacting active ingredients structure and foster the public's legitimacy, credibility, and power. By paying greater attention to them, policymakers could develop and implement more effective public involvement interventions.

摘要

背景

在过去的 50 年中,个体患者在临床咨询层面的参与得到了相当的关注。最近,患者和公众越来越多地参与到改善医疗保健和决策制定的集体决策中。然而,对于指导有效公众参与干预措施的制定和实施的严格评估却缺乏。本文描述了那些可能影响公众成员与专业人员进行富有成效的协商并影响集体医疗保健选择的关键因素。

方法

我们对公众参与制定医疗保健改善优先事项进行了试验过程评估。共有来自加拿大 6 个卫生和社会服务中心的 172 名参与者(包括 83 名患者和公众成员以及 89 名专业人员)参加了试验。我们对 14 次为期一天的会议进行了录像,2 名非参与观察员做了结构化记录。我们使用定性分析展示了公众成员如何影响医疗保健改善的优先事项。

结果

合法性、可信度和权力解释了公众成员影响力的变化。他们的个人患者和护理人员经验、提供结构化的准备会议以及访问社区的基于人群的数据为他们的可信度提供了支持。通过招募平衡的参与者群体以及公众成员有机会从彼此的经验中汲取经验,合法性得到了加强。小组成员的审议、更广泛的公众咨询以及侧重于有效小组流程的调解风格有助于缩小专业人员和公众之间的权力差距。让利益攸关方参与干预措施的设计和实施有助于为公众参与制定政策支持。

结论

一些相互作用的积极因素构建并促进了公众的合法性、可信度和权力。政策制定者如果更加关注这些因素,就可以制定和实施更有效的公众参与干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec3/4089374/610860163b67/milq0092-0319-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec3/4089374/610860163b67/milq0092-0319-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec3/4089374/610860163b67/milq0092-0319-f1.jpg

相似文献

1
What are the key ingredients for effective public involvement in health care improvement and policy decisions? A randomized trial process evaluation.有效促进公众参与医疗保健改善和政策决策的关键要素有哪些?一项随机试验的过程评估。
Milbank Q. 2014 Jun;92(2):319-50. doi: 10.1111/1468-0009.12060.
2
Involving patients in setting priorities for healthcare improvement: a cluster randomized trial.让患者参与医疗保健改进的优先级设定:一项集群随机试验。
Implement Sci. 2014 Feb 20;9:24. doi: 10.1186/1748-5908-9-24.
3
Target for improvement: a cluster randomised trial of public involvement in quality-indicator prioritisation (intervention development and study protocol).目标改进:公众参与质量指标优先级确定(干预措施的制定和研究方案)的整群随机试验。
Implement Sci. 2011 May 9;6:45. doi: 10.1186/1748-5908-6-45.
4
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Realist evaluation of public engagement and involvement in data-intensive health research.对公众参与数据密集型健康研究的现实主义评价。
Res Involv Engagem. 2020 Jun 29;6:37. doi: 10.1186/s40900-020-00215-4. eCollection 2020.
7
Primary Care Research Team Assessment (PCRTA): development and evaluation.基层医疗研究团队评估(PCRTA):开发与评估
Occas Pap R Coll Gen Pract. 2002 Feb(81):iii-vi, 1-72.
8
Understanding the public's role in reducing low-value care: a scoping review.理解公众在减少低价值医疗中的作用:范围综述。
Implement Sci. 2020 Apr 7;15(1):20. doi: 10.1186/s13012-020-00986-0.
9
Designing for Scale and taking scale to account: lessons from a community score card project in Uganda.为扩大规模而设计并考虑规模因素:来自乌干达一个社区记分卡项目的经验教训。
Int J Equity Health. 2021 Jan 11;20(1):31. doi: 10.1186/s12939-020-01367-1.
10
Public appraisal of government efforts and participation intent in medico-ethical policymaking in Japan: a large scale national survey concerning brain death and organ transplant.日本公众对政府在医学伦理政策制定方面的努力及参与意愿的评估:一项关于脑死亡与器官移植的大规模全国性调查
BMC Med Ethics. 2005 Jan 20;6:E1. doi: 10.1186/1472-6939-6-1.

引用本文的文献

1
Bolstering agreement with scarce resource allocation policy using education: a post hoc analysis of a randomized controlled trial.利用教育加强与稀缺资源分配政策的一致性:一项随机对照试验的事后分析
BMC Health Serv Res. 2025 Apr 14;25(1):540. doi: 10.1186/s12913-025-12712-x.
2
[Representation and representativeness in health councils: between formalization and participatory legitimacy].[卫生委员会中的代表性与代表性:在形式化与参与性合法性之间]
Cad Saude Publica. 2025 Feb 7;40(12):e00115524. doi: 10.1590/0102-311XPT115524. eCollection 2025.
3
Public Engagement in Health Policy-Making for Older Adults: A Systematic Search and Scoping Review.

本文引用的文献

1
Involving patients in setting priorities for healthcare improvement: a cluster randomized trial.让患者参与医疗保健改进的优先级设定:一项集群随机试验。
Implement Sci. 2014 Feb 20;9:24. doi: 10.1186/1748-5908-9-24.
2
The unbearable lightness of citizens within public deliberation processes.公共审议过程中公民的难以承受的轻盈感。
Soc Sci Med. 2012 Jun;74(12):1843-50. doi: 10.1016/j.socscimed.2012.02.023. Epub 2012 Mar 20.
3
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
公众参与老年人健康政策制定:系统检索和范围综述。
Health Expect. 2024 Aug;27(4):e70008. doi: 10.1111/hex.70008.
4
Tracking the Development of Community Engagement Over Time: Realist Qualitative Study.追踪社区参与随时间的发展:实证定性研究
J Particip Med. 2024 May 15;16:e47500. doi: 10.2196/47500.
5
Patient influence on general practice service improvement decision making: a participatory research mixed-methods intervention study.患者对全科医疗服务改进决策的影响:一项参与式研究混合方法干预研究。
Br J Gen Pract. 2024 Jul 25;74(745):e552-e559. doi: 10.3399/BJGP.2023.0263. Print 2024 Aug.
6
Initial programme theory development: The first step in a realist evaluation of a cross-sectoral intervention for expectant Danish parents living with psychosocial risks.初始方案理论发展:对丹麦有心理社会风险的孕妇父母进行跨部门干预的现实主义评估的第一步。
PLoS One. 2023 Dec 20;18(12):e0295378. doi: 10.1371/journal.pone.0295378. eCollection 2023.
7
Developing a national strategy of consumer and community involvement (CCI) for women's health research.制定一项针对女性健康研究的消费者与社区参与(CCI)国家战略。
Res Involv Engagem. 2023 Oct 18;9(1):96. doi: 10.1186/s40900-023-00504-8.
8
Patient and citizen participation at the organizational level in health technology assessment: an exploratory study in five jurisdictions.患者和公民在卫生技术评估中的组织层面参与:五个司法管辖区的探索性研究。
Int J Technol Assess Health Care. 2023 Aug 8;39(1):e51. doi: 10.1017/S0266462323000417.
9
Involvement of service user representatives on a healthcare organizational level at Norwegian Healthy Life Centres: A qualitative study exploring health professionals' experiences.在挪威健康生活中心的医疗保健组织层面上让服务使用者代表参与:一项探索健康专业人员经验的定性研究。
PLoS One. 2023 Aug 3;18(8):e0289544. doi: 10.1371/journal.pone.0289544. eCollection 2023.
10
Salient stakeholders: Using the salience stakeholder model to assess stakeholders' influence in healthcare priority setting.重要利益相关者:运用显著利益相关者模型评估利益相关者在医疗保健优先级设定中的影响力。
Health Policy Open. 2021 Jul 17;2:100048. doi: 10.1016/j.hpopen.2021.100048. eCollection 2021 Dec.
Cochrane Database Syst Rev. 2011 Oct 5(10):CD001431. doi: 10.1002/14651858.CD001431.pub3.
4
Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs.患者和公众参与临床实践指南:现有项目的知识综合。
Med Decis Making. 2011 Nov-Dec;31(6):E45-74. doi: 10.1177/0272989X11424401. Epub 2011 Sep 29.
5
IOM sets out "gold standard" practices for creating guidelines, systematic reviews.医学研究所在制定指南、系统评价方面制定了“黄金标准”做法。
JAMA. 2011 May 11;305(18):1846-8. doi: 10.1001/jama.2011.597.
6
Target for improvement: a cluster randomised trial of public involvement in quality-indicator prioritisation (intervention development and study protocol).目标改进:公众参与质量指标优先级确定(干预措施的制定和研究方案)的整群随机试验。
Implement Sci. 2011 May 9;6:45. doi: 10.1186/1748-5908-6-45.
7
Do patients want a choice and does it work?患者想要选择权吗?它起作用吗?
BMJ. 2010 Oct 14;341:c4989. doi: 10.1136/bmj.c4989.
8
Patients' perspectives in health technology assessment: a route to robust evidence and fair deliberation.患者在健康技术评估中的观点:获得稳健证据和公平审议的途径。
Int J Technol Assess Health Care. 2010 Jul;26(3):334-40. doi: 10.1017/S0266462310000395.
9
Patient and public involvement in clinical guidelines: international experiences and future perspectives.患者及公众参与临床指南:国际经验与未来展望。
Qual Saf Health Care. 2010 Oct;19(5):e22. doi: 10.1136/qshc.2009.034835. Epub 2010 Apr 27.
10
Five next steps for a new national program for comparative-effectiveness research.新的国家比较效果研究计划的五个后续步骤。
N Engl J Med. 2010 Mar 18;362(11):970-3. doi: 10.1056/NEJMp1000096. Epub 2010 Feb 17.